The art of Fistuloclysis: Nutritional management of enterocutaneous fistulas

Practical Gastroenterology

Volumn 34, Issue 9, 2010, Pages 47-56

  Willcutts, Kate ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; ATROPINE PLUS DIPHENOXYLATE; LOPERAMIDE; OCTREOTIDE; PROTON PUMP INHIBITOR;

ABDOMINAL ABSCESS; ABDOMINAL PAIN; ABDOMINAL WALL HERNIA; ABSCESS DRAINAGE; ADULT; ANATOMICAL VARIATION; ARTICLE; CASE REPORT; COLON RESECTION; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; DEBRIDEMENT; DIARRHEA; DRUG ABSORPTION; DRUG EFFICACY; ELECTROLYTE INTAKE; ENTERIC FEEDING; ENTEROCUTANEOUS FISTULA; FLUID INTAKE; GASTROSTOMY; HUMAN; INTESTINE ABSORPTION; INTESTINE ANASTOMOSIS; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; JEJUNOSTOMY; LAPAROTOMY; MALE; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PATIENT CARE PLANNING; POSTOPERATIVE COMPLICATION; RARE DISEASE; SEPSIS; SMALL INTESTINE RESECTION; SURGICAL INFECTION; TREATMENT OUTCOME; WOUND DRESSING;

EID: 78650061471     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Berry SM, Fischer JE. Enterocutaneous fistulas. Curr Probl Surg 1994;31(6):469-566.
2. Maykel JA, Fischer JE. Current management of intestinal fistulas. Adv Surg 2003;37:283-299.
3. Teixeira PG, Inaba K, Dubose J, et al. Enterocutaneous fistula complicating trauma laparotomy: a major resource burden. Am Sur, 2009;75(1):30-32.
4. Monod-Broca P. Treatment of intestinal fistulas. Br J Surg 1977;64(10):685-689.
5. Dudrick SJ, Maharaj AR, McKelvey AA. Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg 1999;23(6):570-576.
6. Lloyd DA, Gabe SM, Windsor AC. Nutrition and management of enterocutaneous fistula. Br J Surg 2006;93(9):1045-1055.
7. Datta V, Engledow A, Chan S et al. The management of enterocutaneous fistula in a regional unit in the United kingdom: a prospective study. Dis Colon Rectum 2010;53(2):192-199.
8. Campos AC, Andrade DF, Campos GM, et al. A multivariate model to determine prognostic factors in gastrointestinal fistulas. J Am Coll Surg 1999;188(5):483-490.
9. Haffejee AA. Surgical management of high output enterocutaneous fistulae: a 24-year experience. Curr Opin Clin Nutr Metab Care 2004;7(3):309-316.
10. Hollington P, Mawdsley J, Lim W, et al. An 11-year experience of enterocutaneous fistula. Br J Surg 2004;91(12):1646-1651.
11. Visschers RG, Olde Damink SW, Winkens B et al. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg 2008;32(3):445-453.
12. Levy E, Frileux P, Cugnenc PH, et al. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 1989;76(7):676-679.
13. Draus JM, Jr., Huss SA, Harty NJ, et al. Enterocutaneous fistula: are treatments improving? Surgery 2006;140(4):570-576; discussion 576-578.
14. Teubner A, Morrison K, Ravishankar HR, et al. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg 2004;91(5):625-631.
15. Howard L. Home parenteral nutrition: survival, cost, and quality of life. Gastroenterology 2006;130(2 Suppl 1):S52-59.
16. Evenson AR, Fischer JE. Current management of enterocutaneous fistula. J Gastrointest Surg 2006;10(3):455-464.
17. Lal S, Teubner A, Shaffer JL. Review article: intestinal failure. Aliment Pharmacol Ther 2006;24(1):19-31.
18. Willcutts KF SK, Eddins C. Ostomies and fistulas: a collaborative approach. Practical Gastroenterology 2005;XXIX(11):63-79.
19. McNaughton V, Brown J, Hoeflok J, et al. Summary of best practice recommendations for management of enterocutaneous fistulae from the Canadian Association for Enterostomal Therapy ECF Best Practice Recommendations Panel. J Wound Ostomy Continence Nurs 2010;37(2):173-184.
20. Martinez D, Zibari G, Aultman D, et al. The outcome of intestinal fistulae: the Louisiana State University Medical Center- Shreveport experience. Am Surg 1998;64(3):252-254.
21. MacFadyen BV, Jr., Dudrick SJ, Ruberg RL. Management of gastrointestinal fistulas with parenteral hyperalimentation. Surgery 1973;74(1):100-105.
22. Gonzalez-Pinto I, Gonzalez EM. Optimising the treatment of upper gastrointestinal fistulae. Gut 2001;49 Suppl 4:iv 22-31.
23. Hughes Sea. Care of intestinal stoma and enterocutaneous fistula. In: Intestinal Failure. Edited by Nightingale. Greenwich: Medical Media;2001: 53-63.
24. Lynch AC, Delaney CP, Senagore AJ, et al. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg 2004;240(5):825-831.
25. Fazio VW, Coutsoftides T, Steiger E. Factors influencing the outcome of treatment of small bowel cutaneous fistula. World J Surg 1983;7(4):481-488.
26. Fry DE. Noninvasive imaging tests in the diagnosis and treatment of intra-abdominal abscesses in the postoperative patient. Surg Clin North Am 1994;74(3):693-709.
27. Pickhardt PJ, Bhalla S, Balfe DM. Acquired gastrointestinal fistulas: classification, etiologies, and imaging evaluation. Radiology 2002;224(1):9-23.
28. Cresci GA, Martindale RG. Metabolic and nutritional management of a patient with multiple enterocutaneous fistulas. Nutrition 1997;13(5):446-448; discussion 448-449.
29. Ham M, Horton K, Kaunitz J. Fistuloclysis: case report and literature review. Nutr Clin Pract 2007;22(5):553-557.
30. Farrar K TA. Fistuloclysis distal feeding: information and guidance for patients and healthcare professionals. In. Edited by Hospital SR. Manchester, England; 2003.
31. Lehne. Gastrointestinal Drugs. In: Pharmacology for Nursing Care. Edited by R L. Philadelphia, PA: Saunders Elsevier; 2007: 891-924.
32. Chan L. Opioid analgesics and the gastrointestinal tract. Practical Gastroenterology 2008;XXXII(8):37.
33. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996;334(4):246-254.
34. Sancho JJ, di Costanzo J, Nubiola P, et al. Randomized doubleblind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995;82(5):638641.
35. Nubiola-Calonge P, Badia JM, Sancho J et al. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987;2(8560):672-674.
36. Scott NA, Finnegan S, Irving MH. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study. Acta Gastroenterol Belg 1993;56(3-4):266-270